Results 41 to 50 of about 2,361 (89)

异类叶升麻苷调控PI3K/Akt/mTOR通路抑制人食管鳞状癌ECA109细胞增殖及迁移的机制研究

open access: yesZhongguo shiyan zhenduanxue
目的探究异类叶升麻苷基于PI3K/Akt/mTOR信号通路抑制人食管鳞状癌ECA109细胞增殖及迁移的作用机制。方法采用不同浓度异类叶升麻苷处理ECA109细胞,通过CCK-8与克隆形成实验评估细胞增殖活性;根据CCK-8检测结果分为对照组和异类叶升麻苷低(150 μM)、中(300 μM)和高(400 μM)剂量组,通过划痕愈合实验评估细胞迁移能力,Western blot检测细胞PI3K p85、p-PI3K、Akt、p-Akt、mTOR、p-mTOR 蛋白表达及磷酸化水平,RT ...
宋文潇   +4 more
doaj  

[Anwulignan inhibits malignant phenotypes of gastric cancer cells by antagonizing activation of the JAK1/STAT3 signaling pathway]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Liu X   +9 more
europepmc   +1 more source

[Metformin Inhibits Prostate Cancer Progression via Regulation of the AKT/mTOR Signaling Pathway]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban
Zhang Z   +11 more
europepmc   +1 more source

肾癌分泌IL-8激活ERK促进间充质干细胞迁移的机制

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2014
【目的】 拟探讨肾癌内IL-8的分泌水平及其对骨髓间充质干细胞(MSC)的调节机制,探讨其在归巢中的作用机制?【方法】 ELISA法检测肾癌患者血清以及肾癌细胞分泌的IL-8;免疫组织化学和RT-PCR检测MSC表面IL-8受体表达;迁移实验观察IL-8对MSC的迁移作用;Western blotting 法检测IL-8对MSC内ERK的激活作用?【结果】研究发现正常人群的血液中IL-8为210.4 pg/mL,而肾癌患者血液中IL-8升高至526.7 pg/mL,肾癌细胞株786 ...
doaj  

Home - About - Disclaimer - Privacy